Leg Ulcer in Patient with Sickle Cell Disease on Hydroxyurea

Crossmark: check for updates

Authors

  • Jaya Manjunath George Washington University School of Medicine,Washington, DC 20052, USA
  • Fnu Nutan Division of Hospital Medicine, Department of Dermatology,Virginia Commonwealth University School of Medicine, P. O. Box 980102, Richmond,VA 23298, USA

DOI:

https://doi.org/10.17140/IMOJ-4-114

Keywords:

Leg Ulcer, Sickle cell disease (SCD), Hydroxyurea

Abstract

Leg ulcers are a painful side-effect commonly seen in patients with long-term use of hydroxyurea. We describe an ulcer in a patient with sickle cell disease (SCD) with an 8-year history of hydroxyurea use. Wound care team used cadexomer-iodine topical and collagenase to aid in healing. There are limited options for the treatment of these ulcers beside the cessation of hydroxyurea, a very effective drug in reducing painful sickle cell episodes. It is imperative to be aware of this complication to prevent expensive tests and further work up. Future study into alternative treatment of hydroxyurea-induced leg ulcers for sickle cell patients is necessary.

References

Chakravorty S, Williams TN. Sickle cell disease: A neglected chronic disease of increasing global health importance. Arch Dis Child. 2015; 100(1): 48-53. doi: 10.1136/archdischild-2013-303773

Strouse JJ, Heeney MM. Hydroxyurea for the treatment of sickle cell disease: Efficacy, barriers, toxicity, and management in children. Pediatr Blood Cancer. 2012; 59(2): 365-371. doi: 10.1002/pbc.24178 Case Report | Volume 4 | Number 1|

Agrawal RK, Patel RK, Nainiwal L, Trivedi B. Hydroxyurea in sickle cell disease: Drug review. Indian J Hematol Blood Transfus. 2014; 30(2): 91-96. doi: 10.1007/s12288-013-0261-4

Ault A. US FDA approves first drug for sickle-cell anaemia. The Lancet. 1998; 351(9105): 809. doi: 10.1016/S0140-6736(05)78941-8

Cokic VP, Smith RD, Beleslin-Cokic BB, Njoroge JM, Miller JL, Gladwin MT, et al. Hydroxyurea induces fetal hemoglobin by the nitric oxide–dependent activation of soluble guanylyl cyclase. J. Clin. 2003 Jan 15;111(2):231-239. doi: 10.1172/JCI16672

Quattrone F, Dini V, Barbanera S, Zerbinati N, Romanelli M. Cutaneous ulcers associated with hydroxyurea therapy. J Tissue Vi-ability. 2013; 22(4): 112-121. doi: 10.1016/j.jtv.2013.08.002

Romanelli M, Dini V, Romanelli P. Hydroxyurea-induced leg ulcers treated with a protease-modulating matrix. Arch Dermatol. 2007; 143(10): 1310-1313. doi: 10.1001/archderm.143.10.1310

Brawley OW, Cornelius LJ, Edwards LR, Gamble VN, Green BL, Inturrisi C, et al. National Institutes of Health Consensus Development Conference statement: Hydroxyurea treatment for sickle cell disease. Ann Intern Med. 2008; 148(12): 932-938. doi: 10.7326/0003-4819-148-12-200806170-00220

Sirieix ME, Debure C, Baudot N, Dubertret L, Roux ME, Morel Submit your article to this journal | https://openventio.org/submit-manuscript/ Case Report | Volume 4 | Number 1| Nutan F et al P, et al. Leg ulcers and hydroxyurea: Forty-one cases. Arch Dermatol. 1999; 135(7): 818-820. doi: 10.1001/archderm.135.7.818

Singh A, Xu YJ. The Cell killing mechanisms of hydroxyurea. Genes (Basel). 2016; 7(11): 99. doi: 10.3390/genes7110099

Rahal JA, Ishak RS, Otrock ZK, Maakaron JE, Ghosn S, Ta-her AT. Successful management of hydroxyurea-induced leg ulcers in essential thrombocythemia: Report of 3 cases. Turk J Haematol. 2013; 30(2): 184-187. doi: 10.4274/Tjh.2012.0134

Boyd AS, Neldner KH. Hydroxyurea therapy. J Am Acad Der-matol. 1991; 25(3): 518-524. doi: 10.1016/0190-9622(91)70233-r

Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK. Leg ulcers in sickle cell disease. Am J Hematol. 2010; 85(10): 831- 833. doi: 10.1002/ajh.21838

Akinci B, Yesil S, Atabey A, Ilgezdi S. Hydroxyurea associated leg ulcer succesfully treated with hyperbaric oxygen in a diabetic patient. Exp Clin Endocrinol Diabetes. 2007; 115(02): 143-145. doi: 10.1055/s-2007-956164

Méry L, Girot R, Aractingi S. Topical effectiveness of mol-gramostim (GM-CSF) in sickle cell leg ulcers. Dermatology. 2004; 208(2): 135-137. doi: 10.1159/000076487

Downloads

Published

2020-09-21

How to Cite

Jaya Manjunath, & Fnu Nutan. (2020). Leg Ulcer in Patient with Sickle Cell Disease on Hydroxyurea. Internal Medicine, 4(1), 13–15. https://doi.org/10.17140/IMOJ-4-114

Issue

Vol. 4 No. 1 (2020): Volume 4 Issue 1 2020

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Internal Medicine (IMOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.